Suresh Kumar Nayudu
Overview
Explore the profile of Suresh Kumar Nayudu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahid M, Leung V, Nayudu S, Galiveeti S, Mantri N, Sun H, et al.
Obes Sci Pract
. 2022 Dec;
8(6):748-756.
PMID: 36483126
Background: Since the start of coronavirus disease 2019 (COVID-19) pandemic, several studies have linked obesity with severity of illness as well as mortality in patients with COVID-19. Outcomes of patients...
2.
Makker J, Mantri N, Patel H, Abbas H, Baiomi A, Sun H, et al.
Clin Exp Gastroenterol
. 2021 Oct;
14:405-411.
PMID: 34675588
Background: Patients requiring hospitalization to critical care units are at a higher risk for gastrointestinal (GI) bleeding. Although severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection is predominantly a pulmonary...
3.
Chilimuri S, Mantri N, Gurjar H, Youthjug K, Sun H, Gongati S, et al.
J Natl Med Assoc
. 2021 Sep;
113(6):701-705.
PMID: 34521513
Background: Monoclonal antibody therapy (MAT) is recommended in mild to moderate Coronavirus disease 2019 (COVID-19) patients who are at risk of progressing to severe disease. Due to limited data on...
4.
Mantri N, Patel H, Badipatla K, Sun H, Shaikh D, Gongati S, et al.
Clin Exp Gastroenterol
. 2021 Jun;
14:229-235.
PMID: 34113145
Purpose: infection (CDI) is one of the most common health care-associated infections in the United States. Studies revealed a higher mortality when CDI is associated with liver cirrhosis. We aim...
5.
Patel H, Kumar K, Essrani R, Niazi M, Makker J, Nayudu S
Clin Pract
. 2021 Apr;
11(1):167-173.
PMID: 33800126
Viral infections, alcohol, hepatic steatosis, autoimmunity medications and herbal supplements are common etiologies of hepatitis. Khat (Catha Edulis) is a commonly used recreational substance in East African and Middle Eastern...
6.
Shaikh D, Baiomi A, Mehershahi S, Abbas H, Gongati S, Nayudu S
Case Rep Gastroenterol
. 2021 Jan;
14(3):687-694.
PMID: 33442350
Paclitaxel, a chemotherapeutic agent, is routinely administered for the treatment of various solid organ malignancies. In rare instances, patients receiving infusions of paclitaxel may present with signs of an acute...
7.
Chilimuri S, Sun H, Alemam A, Kang K, Lao P, Mantri N, et al.
J Clin Pharm Ther
. 2020 Oct;
46(2):440-446.
PMID: 33098139
What Is Known And Objective: The coronavirus disease 2019 (COVID-19) associated cytokine activation can lead to a rapid progression into respiratory failure, shock and multiorgan failure. Interleukin-6 (IL-6) is a...
8.
Abbas H, Nayudu S, Ravi M, Saad M, Bathini K, Ravi P, et al.
Gastroenterology Res
. 2020 Sep;
13(4):146-149.
PMID: 32864025
Background: Clopidogrel-based dual anti-platelet therapy (CDAPT) has shown significant benefits in the management of coronary artery disease (CAD), up to 1-year duration. Gastrointestinal bleeding (GIB) is one of the limiting...
9.
Patel H, Makker J, Vakde T, Shaikh D, Badipatla K, Dunne J, et al.
Clin Exp Gastroenterol
. 2019 Dec;
12:449-456.
PMID: 31849510
Purpose: Mouse model experiments have demonstrated an increased infection (CDI) severity with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) use. We aim to evaluate the impact of NSAIDs in humans after a diagnosis...
10.
Abbas H, Rodriguez J, Tariq H, Niazi M, Alemam A, Nayudu S
Gastroenterology Res
. 2019 Mar;
12(1):48-51.
PMID: 30834036
Malignant mesothelioma is a rare neoplasm of the serosal linings. Mesothelioma has been linked to asbestos exposure, with prior asbestos exposure linked to 33-50% of malignant peritoneal mesotheliomas. We describe...